immunity News and Research

RSS

How SARS-CoV-2 infection progresses throughout the respiratory system

Researchers discuss the progression of SARS-CoV-2 infection throughout the respiratory epithelium.

9 Feb 2022

Impact of genetic changes in Omicron variant on an immunodominant T-cell epitope

Researchers describe the impact of changes in the Omicron variant on a uniquely immunodominant spike-encoded CD8+ T-cell epitope.

9 Feb 2022

Research lays the groundwork to better understand and treat Crohn's disease

A paper published this week in Immunity, a leading research journal highlighting discoveries in immunology by Cell Press, lays the groundwork to better understand and treat Crohn's disease, a type of Inflammatory Bowel Disease (IBD).

9 Feb 2022

University of Michigan expert discusses about COVID-19 vaccine for kids under 5

The FDA will consider authorizing two doses of a COVID-19 vaccine for kids under 5 on an emergency basis, with the possibility for a third.

9 Feb 2022

Study compares the neutralizing potential of antibodies against two Omicron variants

A new study investigates if the two SARS-CoV-2 Omicron variants BA.1 and BA.2 are comparable with respect to their ability to evade the host immunity induced by vaccination or prior infection.

9 Feb 2022

Innate immune specificity is driven by the nervous system, study suggests

Research led by Washington State University scientists supports a novel theory that the innate immune system people are born with can respond differently to specific pathogens.

9 Feb 2022

Simulation of SARS-CoV-2 spread in the United States and India

Researchers used an ABM to simulate SARS-CoV-2 spread in the United States and India.

9 Feb 2022

Implications of the SARS-CoV-2 pandemic on influenza epidemics

A new study investigated the effect of low circulating seasonal influenza virus during the SARS-CoV-2 pandemic on the antibody titers against influenza during the same period.

9 Feb 2022

Dynamics and longevity of antibody response from COVID-19 convalescents across the clinical spectrum

Researchers investigated the dynamics and longevity of neutralizing antibody response up to 480 days after the onset of infection in convalescent COVID-19 patients.

9 Feb 2022

Study explores inflammation of endothelial cells by exosomes from COVID-19 patients

In a new study, researchers revealed that the nucleotide-binding oligomerization domain-like receptors or NOD-like receptors family pyrin domain containing 3 (NLRP3) inflammasome is activated by the exosomes from plasma in COVID-19.

9 Feb 2022

Study explores adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants post-immunization in cancer patients

Researchers have conducted a prospective, longitudinal cohort study to analyze COVID-19 immunity in patients with cancer.

9 Feb 2022

Effectiveness of COVID-19 vaccination 9 months post-vaccination for the population of Sweden

Researchers looked at the efficiency of COVID-19 vaccines in preventing infection, hospitalization, and death in the general population of Sweden over the first nine months following vaccination.

9 Feb 2022

Polio, chickenpox, measles, now covid. It’s time to consult history on school vaccine mandates

The rapid spread of omicron across the nation — and the finding that vaccines continue to provide strong protection against severe disease — brings covid-19 one step closer, perhaps, to truly earning its place on the list of diseases that have been tamed by vaccines.

9 Feb 2022

Old FDA-approved drug may protect against lung injury and blood clots in severe COVID-19

An FDA-approved drug that has been in clinical use for more than 70 years may protect against lung injury and the risk of blood clots in severe COVID-19 and other disorders that cause immune-mediated damage to the lungs, according to a preclinical study from researchers at Weill Cornell Medicine and Cold Spring Harbor Laboratory.

8 Feb 2022

UTSA awarded $6.8 million grant to establish a Coccidioidomycosis Collaborative Research Center

Mycology and immunology researchers from The University of Texas at San Antonio have been selected to receive a five-year, $6.8 million grant from the National Institutes of Health to establish a San Antonio-based Coccidioidomycosis Collaborative Research Center (SA-CCRC) focused on developing therapeutics and vaccines against coccidioidomycosis.

8 Feb 2022

immunity News and Research

How SARS-CoV-2 infection progresses throughout the respiratory system

Impact of genetic changes in Omicron variant on an immunodominant T-cell epitope

Research lays the groundwork to better understand and treat Crohn's disease

University of Michigan expert discusses about COVID-19 vaccine for kids under 5

Study compares the neutralizing potential of antibodies against two Omicron variants

Innate immune specificity is driven by the nervous system, study suggests

Simulation of SARS-CoV-2 spread in the United States and India

Implications of the SARS-CoV-2 pandemic on influenza epidemics

Dynamics and longevity of antibody response from COVID-19 convalescents across the clinical spectrum

Study explores inflammation of endothelial cells by exosomes from COVID-19 patients

Study explores adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants post-immunization in cancer patients

Effectiveness of COVID-19 vaccination 9 months post-vaccination for the population of Sweden

Polio, chickenpox, measles, now covid. It’s time to consult history on school vaccine mandates

Old FDA-approved drug may protect against lung injury and blood clots in severe COVID-19

UTSA awarded $6.8 million grant to establish a Coccidioidomycosis Collaborative Research Center

Study shows how gut bacteria could undermine immunity in pancreatic cancer

The B and T cell responses to SARS-CoV-2

PCR data sheds light on the dynamics of interspecies pathogen-pathogen interactions

Reanalysis of the efficacy of COVID-19 vaccines

Efficacy of MVA-CoV2-S vaccination to prevent SARS-CoV-2 cerebral infection and associated damage

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News